Bass, Berry & Sims attorney Jeff Davis authored an article for the American Health Law Association (AHLA) discussing the Health Resources and Services Administration’s (HRSA) approval of a new 340B Rebate Pilot Program. Under the Pilot Program, drug manufacturers will be allowed to offer 340B-discounted drug prices through rebates for ten approved drugs in 2026. … Continued
| less than a minute read
Jeff Davis Discusses HRSA Approval of 340B Drug Rebate Plan
Latest Insights
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2025-12-12-22-46-54-323-693c9b5ef367c9b87b3d8078.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2025-12-12-22-44-11-325-693c9abb2a1eb292d8c17dbd.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2025-11-24-20-38-15-931-6924c2379f4fc45d63f857ac.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2025-11-21-20-53-12-105-6920d138b12284320dbc8f1e.jpg)